Information about atrial fibrillation for healthcare and other professionals.
Stroke survivor and volunteer Emma Day shares her story and why volunteering is important.
The CROMIS-2 study investigated whether signs of small brain bleeds on routine brain scans can help us understand which ischaemic stroke patients with atrial fibrillation are at increased risk of a bleed in the brain when on anticoagulant ‘blood thinning’ drugs.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).
Browse through a list of organisations that can provide support and information about reducing the risk of stroke.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
You might be given blood-thinning medications after you've had a stroke, to help you avoid another one. Or you might need blood-thinning medication if you have a health condition such as a heart problem or blood-clotting disorder which could lead to a stroke.
People with a type of irregular heartbeat called atrial fibrillation (AF) are five times more likely to have a stroke. This guide explains what AF is diagnosed, how it increases your risk of stroke and how it is treated.
Atrial fibrillation is a type of irregular heartbeat that can cause blood clots to form in your heart. Having atrial fibrillation increases your risk of stroke by five times.
You might be prescribed blood-thinning medication to reduce your risk of a TIA or stroke. This guide explains the two types of blood-thinning medication available, antiplatelets and anticoagulants, and how they are used after a stroke or for someone with atrial fibrillation.